These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2795085)

  • 41. Intrathecal baclofen administration during pregnancy: a case series and focused clinical review.
    Morton CM; Rosenow J; Wong C; Kirschner KL
    PM R; 2009 Nov; 1(11):1025-9. PubMed ID: 19942189
    [No Abstract]   [Full Text] [Related]  

  • 42. Epileptic seizures associated with intrathecal baclofen application.
    Kofler M; Kronenberg MF; Rifici C; Saltuari L; Bauer G
    Neurology; 1994 Jan; 44(1):25-7. PubMed ID: 8290085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic intrathecal baclofen administration for control of severe spasticity.
    Lazorthes Y; Sallerin-Caute B; Verdie JC; Bastide R; Carillo JP
    J Neurosurg; 1990 Mar; 72(3):393-402. PubMed ID: 2303874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrathecal application of baclofen in the treatment of spasticity.
    Siegfried J; Rea GL
    Acta Neurochir Suppl (Wien); 1987; 39():121-3. PubMed ID: 3478975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spasticity in spinal cord injured persons: quantitative effects of baclofen and placebo treatments.
    Hinderer SR; Lehmann JF; Price R; White O; deLateur BJ; Deitz J
    Am J Phys Med Rehabil; 1990 Dec; 69(6):311-7. PubMed ID: 2264951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spinal cord stimulation and intrathecal baclofen therapy for patients with severe spasticity after spinal cord injury.
    Biktimirov A; Bryukhovetskiy I; Sharma A; Sharma HS
    Prog Brain Res; 2020; 258():79-99. PubMed ID: 33223042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A benefit-risk assessment of baclofen in severe spinal spasticity.
    Dario A; Tomei G
    Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spasticity therapy reacts to astrocyte GluA1 receptor upregulation following spinal cord injury.
    Gómez-Soriano J; Goiriena E; Taylor J
    Br J Pharmacol; 2010 Nov; 161(5):972-5. PubMed ID: 20662840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The dosage and administration of long-term intrathecal baclofen therapy for severe spasticity of spinal origin.
    Kawano O; Masuda M; Takao T; Sakai H; Morishita Y; Hayashi T; Ueta T; Maeda T
    Spinal Cord; 2018 Oct; 56(10):996-999. PubMed ID: 29895878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Errors and limitations of the multimodality checking methods of defective spinal intrathecal pump systems. Case report.
    Schurch B
    Paraplegia; 1993 Sep; 31(9):611-5. PubMed ID: 8247604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous intrathecal baclofen infusions. An introduction and overview.
    Kamensek J
    Axone; 1999 Mar; 20(3):67-72. PubMed ID: 10401268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
    Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
    J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. H-reflex changes following spinal cord injury.
    Little JW; Halar EM
    Arch Phys Med Rehabil; 1985 Jan; 66(1):19-22. PubMed ID: 3966862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperbaric oxygen therapy: implications for spinal cord injury patients with intrathecal baclofen infusion pumps. Case report.
    Akman MN; Loubser PG; Fife CE; Donovan WH
    Paraplegia; 1994 Apr; 32(4):281-4. PubMed ID: 8022638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Case report of intrathecal baclofen administration in a child with severe spasticity attributable to traumatic brain injury].
    Matsuda R; Nishimura F; Hirabayashi H; Motoyama Y; Mishima H; Park YS; Nakase H; Sakaki T
    Brain Nerve; 2009 Mar; 61(3):313-5. PubMed ID: 19301603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of concentration and mode of intrathecal baclofen administration on soleus H-reflex in patients with muscle hypertonia.
    Stokic DS; Yablon SA
    Clin Neurophysiol; 2012 Nov; 123(11):2200-4. PubMed ID: 22595326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrathecal baclofen for spasticity.
    Dralle D; Müller H; Zierski J; Klug N
    Lancet; 1985 Nov; 2(8462):1003. PubMed ID: 2865464
    [No Abstract]   [Full Text] [Related]  

  • 60. Permanent mechanical deformation of an intrathecal baclofen pump secondary to scuba diving: a case report.
    Draulans N; Roels E; Kiekens C; Nuttin B; Peers K
    Spinal Cord; 2013 Nov; 51(11):868-9. PubMed ID: 23689393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.